RightFit
RecruitingPhase not listed

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
30 Years to 75 Years
Sex
Female only
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Patients complete a questionnaire and have their medical records reviewed on study."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks at whether women with a moderately higher risk of breast cancer get their recommended screening tests. It also looks at what helps them get screened and what gets in the way.

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Women ages 30 to 75.
  • Have either a harmful or likely harmful change in the ATM, CHEK2, BARD1, RAD51C, or RAD51D gene, or a 20% to 40% lifetime breast cancer risk based on the Tyrer-Cuzick V8.0B risk tool.
  • Had a breast cancer risk check by a genetic counselor at USC Norris or LA General Hospital in 2021 or later, at least 12 months ago.
  • Were told to get a breast MRI, a mammogram, or both each year, starting at the risk check. These tests take pictures to look for breast cancer.
  • Speak English or Spanish.

Who can't join

  • Had breast cancer before genetic counseling at the University of Southern California (USC).
  • Had any cancer that had spread to other parts of the body at the time of the genetic counseling risk check.
  • Have died.
  • Had surgery to remove breast tissue to lower cancer risk before the genetic counseling risk check.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * \* \>= 30 years * =\< 75 years * Women with either: * Genetic test results showing moderately increased breast cancer risk due to a pathogenic/likely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, or RAD51D (Mutation carrier group) OR * Calculated lifetime breast cancer risk estimates between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric risk group) * Patients provided breast cancer risk assessments by genetic counselors at USC Norris or LA General Hospital beginning in 2021 and at least 12 months ago * Women recommended to undergo annual breast MRI and/or annual mammogram beginning at the time of their genetic counseling risk assessment * English or Spanish speaking patients Exclusion Criteria: * \* History of breast cancer before genetic counseling at University of Southern California (USC) * Any metastatic cancer diagnosis at time of genetic counseling risk assessment * Deceased * Patient underwent a risk reducing mastectomy before their genetic counseling risk assessment

Study sites (2)

CA